Li Chenrui
Life Science
Northwestern Polytechnical University
Shaanxi
Language: Chinese, English
Contact
Chinese Medicine Pharmacology Metabolic Diseases Osteoporosis Atherosclerosis Natural Drugs Pharmacokinetics Drug Interactions Western Medicine Research
Areas of Focus
  • Pharmacology of Chinese medicine
  • Mechanisms of metabolic diseases and natural drug protection
  • Pharmacokinetics and drug interactions in combined Chinese and Western medicine
Work Experience
  • 2016.04-Present - Northwest Polytechnical University, School of Life Sciences - Associate Professor
  • 2015.03-2016.03 - Chinese University of Hong Kong, School of Pharmacy - Visiting Scholar
  • 2014.03-2016.03 - Northwest Polytechnical University, School of Life Sciences - Lecturer
  • 2012.02-2014.02 - Northwest Polytechnical University, School of Life Sciences - Postdoctoral Researcher
  • 2011.01-2012.01 - Chinese University of Hong Kong, School of Pharmacy - Research Assistant
Academic Background & Achievements
  • PhD: Not mentioned
  • Hosted multiple research projects funded by national and provincial science foundations
Publications
  • Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination-in vitro and in vivo investigation using a taxane-resistant prostate cancer model, Li CR, Wang Z, Wang Q, Ka Yan Ho RL, Huang Y, Chow MSS, Kei Lam CW, Zuo Z, 2017
  • Non-linear pharmacokinetics of piperine and its herb-drug interactions with docetaxel in Sprague-Dawley rats, Li CR, Wang Q, Ren TJ, Zhang YF, Lam CWK, Chow MSS, Zuo Z, 2016
  • Pharmacological effects and pharmacokinetic properties of icariin, the major bioactive component in Herba Epimedii, Li CR, Li Q, Mei QB, Lu TL, 2015
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.